OraSure’s MIRIAD results
This article was originally published in The Gray Sheet
Executive Summary
OraQuick rapid HIV test use in point-of-care labor and delivery settings allows an average 45 minute turn-around time - more than four times faster than the 3.5 hour average needed when the same test is performed in a lab, according to CDC's Maternal Infant Rapid Intervention at Delivery study. Started in November 2001, MIRIAD tested 380 women in Chicago with 100% accuracy, finding and treating three who were HIV positive. OraQuick was approved by FDA in November 2002. CDC's previous purchase of 250,000 of the tests will be finalized in January (1"The Gray Sheet" June 30, 2003, In Brief)...